Titan S.A. (TTCIF)

Elevation Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,092	3,095	1,767	974	1,172	1,292
Market Cap Growth	43.48%	75.20%	81.49%	-16.93%	-9.32%	-26.33%
Enterprise Value	3,367	3,825	2,646	1,978	2,032	2,259
Last Close Price	42.50	43.35	20.70	-	-	-
PE Ratio	12.61	10.34	5.95	8.31	11.21	938.28
PS Ratio	0.99	1.13	0.63	0.40	0.60	0.66
PB Ratio	1.38	1.64	1.01	0.64	0.77	0.83
P/TBV Ratio	1.79	2.11	1.34	0.89	1.08	1.18
P/FCF Ratio	12.01	12.58	6.38	22.13	8.68	4.46
P/OCF Ratio	5.79	6.60	3.56	3.73	4.71	3.53
EV/Sales Ratio	1.10	1.40	0.94	0.81	1.04	1.15
EV/EBITDA Ratio	4.93	6.60	4.59	5.93	7.05	6.88
EV/EBIT Ratio	6.90	8.90	6.11	10.34	13.46	12.71
EV/FCF Ratio	13.08	15.55	9.55	44.98	15.05	7.79
Debt / Equity Ratio	0.36	0.41	0.59	0.63	0.59	0.70
Debt / EBITDA Ratio	1.21	1.29	1.74	2.76	2.97	3.15
Debt / FCF Ratio	3.17	3.14	3.74	21.94	6.68	3.76
Asset Turnover	0.79	0.81	0.82	0.81	0.64	0.58
Inventory Turnover	4.85	4.64	4.82	5.40	5.07	4.88
Quick Ratio	1.43	0.78	0.62	0.57	0.57	0.65
Current Ratio	2.03	1.77	1.21	1.42	1.44	1.22
Return on Equity (ROE)	12.28%	17.05%	18.15%	8.00%	7.01%	0.09%
Return on Assets (ROA)	7.66%	7.99%	7.89%	3.95%	3.10%	3.28%
Return on Capital (ROIC)	10.09%	10.21%	10.11%	5.02%	3.86%	4.03%
Return on Capital Employed (ROCE)	14.70%	15.10%	16.60%	7.40%	5.90%	6.80%
Earnings Yield	7.93%	9.67%	16.81%	12.04%	8.92%	0.11%
FCF Yield	8.32%	7.95%	15.68%	4.52%	11.52%	22.43%
Payout Ratio	30.36%	21.93%	16.75%	35.22%	34.80%	1564.39%
Buyback Yield / Dilution	-0.19%	0.45%	1.51%	-1.09%	2.97%	2.94%
Total Shareholder Return	-	0.45%	1.51%	-1.09%	2.97%	2.94%

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.